Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson's Disease
Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...
deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk
New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing ...